Model No. | Nomenclature | Genotype |
---|---|---|
9659-F | CB6F1-Map4k3Tg(HLA-A*0201/H2-Kb)A*0201/Tac | tg/wt |
9659-M | CB6F1-Map4k3Tg(HLA-A*0201/H2-Kb)A*0201/Tac | tg/wt |
Model No. | Nomenclature | Genotype |
---|---|---|
9659-F | CB6F1-Map4k3Tg(HLA-A*0201/H2-Kb)A*0201/Tac | tg/wt |
9659-M | CB6F1-Map4k3Tg(HLA-A*0201/H2-Kb)A*0201/Tac | tg/wt |
Nomenclature: CB6F1-Map4k3Tg(HLA-A*0201/H2-Kb)A*0201/Tac
Origin
The HLA-A2.1 model was generated by Pharmexa-Epimmune. The model was created by microinjecting a chimeric transgene combining a fragment of the genomic clone of the human HLA-A*0201 gene that included leader sequence, α1 and α2 domains ligated to a fragment of the murine H2-Kb gene containing the α3, transmembrane and cytoplasmic domains. This transgene was microinjected into C57BL/6J zygotes. The resultant mice from Founder Line A*0201 were on an inbred C57BL/6J background. Taconic received stock from Pharmexa-Epimmune in 2008. The line was embryo transfer derived, and the colony is maintained through breeding of homozygous males and females. In the production colony, wild type BALB/cAnNTac females are bred to homozygous males on the C57BL/6J background to produce CB6F1 pups, which are sold under model #9659.
Initial Publication:
Vitiello A, Marchesini D, Furze J, Sherman LA, Chesnut RW. (1991) Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J Exp Med 173(4):1007-15.
* This reference describes the transgene incorporated into line 9659. Pharmexa-Epimmune remade the line later directly onto B6/J zygotes. This is the mouse line that Taconic offers as Model # 9659.
Need more info? Click the live chat button or Contact Us
Packing Practices
Taconic standard practice is to recombine animals of different home cages and/or ages from a single model and sex during packing, except in specific cases where Taconic's animal welfare policy prohibits recombination due to aggression or other concerns. When an order is fulfilled with animals from more than one week of birth, this standard practice results in animals from a range of birth weeks packed together in a single TTC. When an order is fulfilled with animals from genotyped models, this standard practice results in animals from different home cages packed together in a single TTC.
Customers who wish to keep animals from different weeks of birth separated should place orders with the special instruction "Divide and label by age." Note that this special request can result in increased costs for additional Taconic Transit Cages, dividers and/or freight charges.
Taconic discourages other types of custom packing requests as they can have a negative impact on animal welfare. Learn more.
Conditions of Use for Taconic Transgenic Models™
Taconic Transgenic Models™ (Models) are produced and distributed under rights to patents and intellectual property licensed from various institutions. Taconic sells the Models to purchasers, grants to each purchaser a right under Taconic's rights in such licensed patents and intellectual property to use the purchased Model in consideration of purchasers' acknowledgement of and agreement to the Terms and Conditions for Taconic Models, Products and Services and the following terms of use:
Age in Weeks | Quantity 1 - 999 |
3 to 10 | $433.00 |
Age in Weeks | Quantity 1 - 999 |
3 to 10 | $433.00 |
Age in Weeks | Quantity 1 - 999 |
3 to 10 | €388,00 |
Age in Weeks | Quantity 1 - 999 |
3 to 10 | €388,00 |
Age in Weeks | Quantity 1 - 999 |
3 to 10 | $250.00 |
Age in Weeks | Quantity 1 - 999 |
3 to 10 | $250.00 |
Age in Weeks | Quantity 1 - 999 |
3 to 10 | €224,00 |
Age in Weeks | Quantity 1 - 999 |
3 to 10 | €224,00 |
Need help choosing the right Taconic Biosciences health standard for your research?
Use the Health Standard Selector to enter your exclusion list. The tool will tell you which health standards meet your requirements.
Speak with a PhD-level Field Application Scientist who can help you select the most appropriate model and maximize your experimental success.